Evidence map›Paper›PMID 42020555›Full record

ArticleScientific reports2026

A multimodal approach integrating NK cell-associated gene signatures and pathomics to predict colon adenocarcinoma prognosis.

Kaiqiang Yang, Qiange Lin, Jia Zhu, Tao Zhu, Guoxiang Fu

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Frontiers in molecular biosciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kaiqiang Yang *Department of Pathology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, China.
Qiange Lin *School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Jia ZhuDepartment of Pathology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, China.
Tao ZhuDepartment of Pathology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, China.
Guoxiang FuDepartment of Pathology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, China. 3201013@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-cell RNA sequencing (scRNA-seq) was used to analyze the GSE161277 dataset to identify candidate NK cell–associated genes. A prognostic model based on NK cell-associated gene signatures was constructed via LASSO regression. Deep learning using the Clustering-constrained Attention Multiple Instance Learning model extracted pathomic features from 458 TCGA-COAD whole-slide images. A multimodal prognostic framework was developed by integrating scRNA-seq, transcriptomic, pathomic, and clinical data. scRNA-seq analysis of the GSE161277 dataset revealed diverse immune and stromal cell populations within the microenvironment, highlighting its cellular heterogeneity. Based on these data, NK cell-associated candidate genes were identified for subsequent prognostic modeling. The NK cell-associated gene signature prognostic model showed high accuracy in predicting overall survival in TCGA COAD cohort, with a concordance index (C-index) of 0.835. The pathology-based prognostic model achieved a C-index of 0.871. The multimodal prognostic framework achieved a C-index of 0.889, outperforming single-modality approaches. This study proposes a multimodal prognostic framework integrating NK cell-associated molecular features, pathomic features, and clinical variables.

Indexed as

AdenocarcinomaColonic NeoplasmsKiller Cells, NaturalGene Expression ProfilingGene Expression Regulation, NeoplasticHumansPrognosisSingle-Cell Gene Expression AnalysisTranscriptomeTumor MicroenvironmentColon adenocarcinomaDeep learningMultimodal prognostic modelNatural killer cellsPathomicsSingle-cell RNA sequencing

Identifiers

PMID42020555
PMCPMC13269797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.